SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $228,286 | -40.2% | 4,855 | -46.7% | 0.00% | -100.0% |
Q1 2023 | $381,882 | +19.0% | 9,101 | +10.9% | 0.00% | 0.0% |
Q3 2022 | $321,000 | +39.0% | 8,207 | +14.4% | 0.00% | – |
Q2 2022 | $231,000 | -92.6% | 7,172 | -86.9% | 0.00% | -100.0% |
Q2 2021 | $3,128,000 | -20.5% | 54,860 | +5.8% | 0.01% | -30.0% |
Q1 2021 | $3,937,000 | -9.0% | 51,847 | +3.2% | 0.01% | -9.1% |
Q4 2020 | $4,327,000 | +93.5% | 50,224 | +37.1% | 0.01% | +83.3% |
Q3 2020 | $2,236,000 | +88.9% | 36,639 | +28.6% | 0.01% | +50.0% |
Q2 2020 | $1,184,000 | +95.4% | 28,482 | +29.5% | 0.00% | +100.0% |
Q1 2020 | $606,000 | -74.2% | 22,000 | -32.8% | 0.00% | -71.4% |
Q4 2019 | $2,345,000 | -74.2% | 32,739 | -49.4% | 0.01% | -69.6% |
Q3 2019 | $9,073,000 | -21.0% | 64,708 | +3.2% | 0.02% | -39.5% |
Q2 2019 | $11,484,000 | +29.0% | 62,679 | +11.8% | 0.04% | +26.7% |
Q1 2019 | $8,900,000 | +1288.5% | 56,039 | +1067.0% | 0.03% | +1400.0% |
Q4 2018 | $641,000 | +3.1% | 4,802 | +8.2% | 0.00% | 0.0% |
Q3 2018 | $622,000 | -64.7% | 4,437 | -60.6% | 0.00% | -66.7% |
Q2 2018 | $1,764,000 | +176300.0% | 11,274 | +225380.0% | 0.01% | – |
Q1 2018 | $1,000 | -99.6% | 5 | -99.9% | 0.00% | -100.0% |
Q3 2016 | $263,000 | +3657.1% | 5,702 | +2336.8% | 0.00% | – |
Q2 2016 | $7,000 | 0.0% | 234 | +7.3% | 0.00% | – |
Q1 2016 | $7,000 | -46.2% | 218 | -3.5% | 0.00% | – |
Q4 2015 | $13,000 | -94.8% | 226 | -96.2% | 0.00% | -100.0% |
Q3 2015 | $250,000 | -31.7% | 5,916 | +18.0% | 0.00% | -33.3% |
Q2 2015 | $366,000 | +49.4% | 5,015 | +2.6% | 0.00% | +50.0% |
Q1 2015 | $245,000 | +12150.0% | 4,890 | +7787.1% | 0.00% | – |
Q4 2014 | $2,000 | – | 62 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 312,000 | $29,886,000 | 5.11% |
DAFNA Capital Management LLC | 104,306 | $9,991,000 | 4.97% |
Palo Alto Investors LP | 850,977 | $81,515,000 | 4.34% |
BB BIOTECH AG | 1,375,229 | $131,733,000 | 4.22% |
Eventide Asset Management | 936,000 | $89,659,000 | 3.97% |
TRV GP II, LLC | 37,362 | $3,579,000 | 3.56% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 146,179 | $14,002,000 | 2.11% |
SUFFOLK CAPITAL MANAGEMENT LLC | 111,908 | $10,720,000 | 2.06% |
OAK RIDGE INVESTMENTS LLC | 231,483 | $22,174,000 | 1.60% |
Rhenman & Partners Asset Management AB | 137,339 | $13,156,000 | 1.50% |